Clinical Trials in Chicago

Showing 5061-5080 of 20,493 trials

9-ING-41 in Pediatric Patients With Refractory Malignancies.

NCT04239092

9-ING-41 has anti-cancer clinical activity with no significant toxicity in adult patients. This Phase 1 study will study its efficacy in paediatric patients with advanced malignancies.

Refractory CancerRefractory NeoplasmCancer Pediatric+8 more

Actuate Therapeutics Inc.40 participantsStarted Jun 2020

San Francisco, California, United States • Aurora, Colorado, United States • Chicago, Illinois, United States +6 more locations

RECRUITINGPhase 32.2 miles

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

NCT05261139

The purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after you take it), and efficacy (how well a study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID-19). The study medicine will be given to patients under 18 years of age with COVID-19 that are not hospitalized but are at risk for severe disease.

COVID-19

Pfizer160 participantsStarted Mar 2022

Phoenix, Arizona, United States • Los Angeles, California, United States • Los Angeles, California, United States +70 more locations

9-ING-41 in Pediatric Patients With Refractory Malignancies.

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

Find Trials by Condition in Chicago

CCHS Secure Health-hub Advancing Research Efforts (CCHS SHARE)

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

Neuromodulation and Yoga for Mild Traumatic Brain Injury and Chronic Pain

Expanded Clinical Study of the Tendyne Mitral Valve System

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study

A Study to Compare Nighttime Aligners to Daytime Aligners

Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction

Valved Graft PMCF Study

Ceramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS)

Long Term Follow Up for CTSN Mitral Valve Repair Studies

ALTO-100 in Bipolar Disorder With Depression (BD-D)

Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEE

Trial to Evaluate Dietary Supplements to Maintain Gut Health During Travel

Study to Assess AFM24 in Advanced Solid Cancers